207 related articles for article (PubMed ID: 27650414)
21. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
Ichimura Y; Waguri S; Sou YS; Kageyama S; Hasegawa J; Ishimura R; Saito T; Yang Y; Kouno T; Fukutomi T; Hoshii T; Hirao A; Takagi K; Mizushima T; Motohashi H; Lee MS; Yoshimori T; Tanaka K; Yamamoto M; Komatsu M
Mol Cell; 2013 Sep; 51(5):618-31. PubMed ID: 24011591
[TBL] [Abstract][Full Text] [Related]
22. Role of human Keap1 S53 and S293 residues in modulating the binding of Keap1 to Nrf2.
Wei S; Pei Y; Wang Y; Guan H; Huang Y; Xing T; Johnson RW; Wang D
Biochimie; 2019 Mar; 158():73-81. PubMed ID: 30576774
[TBL] [Abstract][Full Text] [Related]
23. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
24. KEAP1/NRF2 axis regulates H
He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
[TBL] [Abstract][Full Text] [Related]
25. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
26. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
27. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.
Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
[TBL] [Abstract][Full Text] [Related]
29. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
31. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
Li C; Wu H; Wang S; Zhu J
Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
[TBL] [Abstract][Full Text] [Related]
32. Targeting Keap1 by miR-626 protects retinal pigment epithelium cells from oxidative injury by activating Nrf2 signaling.
Xu XZ; Tang Y; Cheng LB; Yao J; Jiang Q; Li KR; Zhen YF
Free Radic Biol Med; 2019 Nov; 143():387-396. PubMed ID: 31446056
[TBL] [Abstract][Full Text] [Related]
33. CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway.
Chen J; Jiang S; Shao H; Li B; Ji T; Staiculescu D; He J; Zhao J; Cai L; Liang X; Xu J; Cai X
Sci China Life Sci; 2022 Oct; 65(10):1998-2016. PubMed ID: 35380342
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease.
To K; Okada K; Watahiki T; Suzuki H; Tsuchiya K; Tokushige K; Yamamoto M; Ariizumi SI; Shoda J
Cancer Med; 2023 Oct; 12(19):19423-19437. PubMed ID: 37732511
[TBL] [Abstract][Full Text] [Related]
35. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract][Full Text] [Related]
36. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.
Huang CF; Zhang L; Ma SR; Zhao ZL; Wang WM; He KF; Zhao YF; Zhang WF; Liu B; Sun ZJ
PLoS One; 2013; 8(12):e83479. PubMed ID: 24386210
[TBL] [Abstract][Full Text] [Related]
38. Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma.
Chen F; Xiao M; Feng J; Wufur R; Liu K; Hu S; Zhang Y
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142252
[TBL] [Abstract][Full Text] [Related]
39. KEAP1/NRF2 signaling pathway mutations in cervical cancer.
Chu XY; Li ZJ; Zheng ZW; Tao YL; Zou FX; Yang XF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4458-4466. PubMed ID: 30058679
[TBL] [Abstract][Full Text] [Related]
40. Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
Cho HY; Kim K; Kim YB; Kim H; No JH
Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]